The Med Ai

How We Can Force Big Pharma into Sharing Data for the Benefit of Cancer  Researchers

  • Requiring laboratories to commit to cancer research data sharing
  • Safeguarding Privacy, Fostering Trust

The plan: A Paradigm Shift of Necessity:

In a disquieting revelation, an NPR report underscores cancer hospitals and health companies shift away from the primary goal of cancer research towards a concerning practice. re-selling the huge amount of patient-donated medical data pertaining to cancer tumors that there were supposedly for research purposes, are being exploited to create new profit-driven products and companies This has evolved into a multi-billion-dollar industry.

I want to shed light on this issue and then a strategic solution that will quickly put an end to this practice so we can quickly propel cancer research forward and catalyze innovation:

This deviation from the intended research purpose, driven by financial gains, highlights a troubling divergence from the pursuit of cancer cure advancements. This trend, fueled by substantial financial gains, raises concerns about the potential undermining of efforts to advance cancer treatments. The shift towards commercial interests over the original intent of finding a cure raises important questions about the ethical compass guiding cancer research and its commitment to helping patients.

The solution:

Following discussions with fellow members of the international cancer research committee, we devised a plan. The plan is to recommend that cancer patients who want to donate their biopsy tumor to further research require the hospitals and health plan corporations to sign this form, otherwise, the hospitals and health plan corporations do not have the right to their cancer tissue. This will compel laboratories by necessity to share the data that they are collecting with researchers freely instead of re-selling it for corporate profit. The outcome of this initiative will be the transparent and unrestricted sharing of collected cancer research data, facilitating access and collaboration for every researcher. while ensuring the protection of the patient’s personal information by removing sensitive information like birth name and SSN

This strategic approach transforms sharing from an option to an imperative. Given that hospitals have their own data needs, this strategy effectively empowers patients by placing control squarely in their hands.

Benefits: Rewards Arising from Ethical Cancer Tissue Donation Accelerated Discoveries,

Accelerated Discoveries, Shared Rewards:

Imagine the ripple effect of open data access. Researchers armed with a treasure trove of information can expedite discoveries, leading to quicker breakthroughs in treatments and interventions. This led to the discovery of a covid vaccine in mere months, vaccines which historically would have taken at least a decade to create. This not only benefits patients but also holds potential financial rewards for pharmaceutical companies as their innovations gain traction in the medical community.

Changing the Conversation:

The strategy of compelling big pharma to share research data is gaining traction, shifting the narrative from profit-centric to patient-centric. As awareness spreads, the pressure mounts, and corporations find themselves in a position where every new patient requires them not to sell their data and to share it with other researchers for free.

Seizing the Opportunity:

By advocating for this strategy, you become an agent of change. Your voice, combined with countless others, can reshape the landscape of medical research. Sharing this article and this information is more than just an action—it’s a step toward a future where barriers to progress are dismantled, where breakthroughs are accelerated, and where patients are at the heart of medical advancements.

In conclusion, the strategy of compelling Big Pharma to share research data is not only feasible but also a game-changing approach that aligns with the broader interests of society. As the momentum grows and the call for transparency amplifies, we have an unprecedented opportunity to drive a paradigm shift that benefits us all. Stand with us, share this message, and be part of a movement that has the potential to revolutionize medical research for generations to come.

Our aim is to get cancer research expedited. Sign up to get update on our progress.